Dr. Hagins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Wheeler St
Savannah, GA 31405Phone+1 912-356-2953Fax+1 912-356-2465
Education & Training
HCA Healthcare/Mercer University School of Medicine/Memorial Health University Medical CenterResidency, Family Medicine, 1989 - 1992
Morehouse School of MedicineClass of 1989
Certifications & Licensure
GA State Medical License 1992 - 2025
Publications & Presentations
PubMed
- 408 citationsDolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferi...Pedro Cahn, Anton Pozniak, Horacio Mingrone, Andrey Shuldyakov, Carlos Brites
Lancet. 2013-08-24 - 94 citationsBictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 resul...David A. Wohl, Yazdan Yazdanpanah, Axel Baumgarten, Amanda Clarke, Melanie A. Thompson
The Lancet. HIV. 2019-06-01 - 4 citationsPatient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced IndividualsSarah-Jane Anderson, Miranda Murray, David Cella, Robert M. Grossberg, Debbie Hagins
The Patient. 2021-06-28
Press Mentions
Switching HIV Regimens Safe in African-AmericansMarch 10th, 2020
First Efficacy Trials on Switch to RPV/FTC/TAF for HIV Yield Positive ResultsSeptember 20th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
